Vaccine Delivery Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently published an in-depth analysis of the global Vaccine Delivery Devices Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Vaccine Delivery Devices Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The Vaccine Delivery Devices market is projected to witness a compound annual growth rate (CAGR) of 7.1%, leading to a growth in value from US$ 5,160.0 million in 2023 to US$ 8,340.2 million by the conclusion of 2030.

Key Insights:

Vaccine Delivery Devices Market Size (2023E): US$ 5,160.0 Million
Projected Market Value (2030F): US$ 8,340.2 Million
Global Market Growth Rate (CAGR 2023 to 2030): 7.1%
Historical Market Growth Rate (CAGR 2018 to 2022): 6.3%

Vaccine Delivery Devices Market- Report Scope:

The surge in infectious diseases necessitates increased vaccine demand, driving the need for advanced vaccine delivery technologies. Governments and healthcare organizations expand vaccination programs in response to rising infections, creating a larger market for diverse vaccine delivery systems. Ongoing threats, such as new pathogens and outbreaks like COVID-19, highlight the global demand for efficient pandemic preparedness, emphasizing the importance of innovative vaccine delivery methods. Governments allocate substantial funds to combat infectious diseases, fueling the growth of the vaccine delivery devices market. International organizations and NGOs actively participate in global health initiatives, further boosting the demand for global vaccine delivery systems. As the necessity for vaccinations rises, manufacturers invest in research and development to create cutting-edge, effective, and patient-friendly delivery systems.

Market Growth Drivers:

The expansion of immunization programs is driving the demand for reliable vaccine delivery systems. Increasing vaccination targets across diverse demographics necessitates a wider range of customized delivery systems, fostering market growth. Manufacturers are innovating to meet the unique needs of new vaccines as immunization programs grow, especially addressing emerging infectious diseases. The geographical expansion of immunization efforts into underserved communities provides opportunities for versatile solutions adaptable to different healthcare settings. The cultural shift towards preventive healthcare, supported by government funding and public health initiatives, encourages the use of effective and user-friendly vaccine delivery methods, further propelling market growth.

Market Restraints:

Market growth faces hindrances due to high initial costs associated with cutting-edge vaccine delivery technologies, particularly in resource-limited environments. Financial constraints in healthcare institutions, both private and public, may lead to delays or reluctance in adopting new technologies, creating inequalities in access. Additionally, needle phobia and vaccine hesitancy pose challenges by decreasing immunization acceptability, potentially limiting the market for inventive vaccine delivery systems. Reluctance to vaccinate can result in reduced vaccination rates, impacting public health goals and increasing the risk of preventable disease outbreaks.

Market Opportunities:

The integration of digital health is revolutionizing immunization procedures, allowing real-time monitoring and remote patient compliance tracking. Connected vaccine delivery equipment provides valuable data on administration rates, patient reactions, and supply chain details, empowering healthcare providers to optimize immunization plans. Enhanced patient engagement is achieved through features like reminders, post-vaccination support, and personalized information, fostering adherence and improved healthcare outcomes. Integration with telehealth platforms enables remote consultations, promoting inclusivity and accessibility. Devices with digital health capabilities support real-time monitoring and reporting of immunization campaigns, facilitating quick responses to emerging infectious diseases and efficient crisis management. Automated inventory management ensures a steady supply of vaccinations, reduces waste, and streamlines documentation through integration with electronic health records.

Key Questions Answered in the Report:

What are the key factors driving the growth of the Vaccine Delivery Devices Market?
Which industry verticals are driving the demand for Vaccine Delivery Devices?
How are technological advancements reshaping the competitive landscape of the Vaccine Delivery Devices Market?
Who are the leading players in the global Vaccine Delivery Devices Market?
What are the emerging trends and future prospects in the global Vaccine Delivery Devices Market?

Competitive Intelligence and Business Strategy:

Key players in the sector, such as Becton Dickinson & Company (BD) and SCHOTT AG, lead the way in vaccine delivery devices and packaging. BD, a preferred provider for immunization programs, excels in traditional syringes and needles and innovates in vector delivery devices (VDDs). Their needle-free injectors and microneedle patches address comfort, waste, and patient compliance, with a focus on customization for specific vaccines. BD invests significantly in R&D, developing next-gen VDDs with features like data tracking and thermostability. Environmental sustainability is a priority, with a commitment to biodegradable materials. SCHOTT, renowned for premium glass vials, sets the standard for vaccine packaging with durable, clear, and chemically resistant solutions. Novel formulations like OPTIMA(TM) vials offer improved drug compatibility, longer shelf life, and a smaller environmental footprint. SCHOTT collaborates with VDD manufacturers and engages in R&D partnerships to advance vaccine packaging technologies and compatibility with VDDs.

Key Companies Profiled:

Becton Dickinson & Company
Bioject Medical Technologies, Inc.
Inovio Pharmaceutical Inc.
PharmaJet
Vaxxas
Gerresheimer AG
SCHOTT AG
Corium International, Inc.
3M

Vaccine Delivery Devices Market Segmentation:

By Device:

Syringes
Jet Injectors
Other Devices

By Route of Administration:

Intradermal
Intramuscular
Subcutaneous
Other

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33912

1. Executive Summary

1.1. Global Vaccine Delivery Devices Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Device Lifecycle Analysis
2.4. Vaccine Delivery Devices Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Route of Administration Landscape

3. Global Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Vaccine Delivery Devices Market Outlook: Device
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Device, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
  - 3.3.3.1. Syringes
  - 3.3.3.2. Jet Injectors
  - 3.3.3.3. Other Devices
3.4. Market Attractiveness Analysis: Device
3.5. Global Vaccine Delivery Devices Market Outlook: Route of Administration
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
  - 3.5.3.1. Intradermal
  - 3.5.3.2. Intramuscular
  - 3.5.3.3. Subcutaneous
  - 3.5.3.4. Other
3.6. Market Attractiveness Analysis: Route of Administration

4. Global Vaccine Delivery Devices Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Device
- 5.3.3. By Route of Administration
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 5.5.1. Syringes
- 5.5.2. Jet Injectors
- 5.5.3. Other Devices
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 5.6.1. Intradermal
- 5.6.2. Intramuscular
- 5.6.3. Subcutaneous
- 5.6.4. Other
5.7. Market Attractiveness Analysis

6. Europe Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Device
- 6.3.3. By Route of Administration
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 6.5.1. Syringes
- 6.5.2. Jet Injectors
- 6.5.3. Other Devices
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 6.6.1. Intradermal
- 6.6.2. Intramuscular
- 6.6.3. Subcutaneous
- 6.6.4. Other
6.7. Market Attractiveness Analysis

7. East Asia Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Device
- 7.3.3. By Route of Administration
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 7.5.1. Syringes
- 7.5.2. Jet Injectors
- 7.5.3. Other Devices
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 7.6.1. Intradermal
- 7.6.2. Intramuscular
- 7.6.3. Subcutaneous
- 7.6.4. Other
7.7. Market Attractiveness Analysis

8. South Asia & Oceania Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Device
- 8.3.3. By Route of Administration
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 8.5.1. Syringes
- 8.5.2. Jet Injectors
- 8.5.3. Other Devices
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 8.6.1. Intradermal
- 8.6.2. Intramuscular
- 8.6.3. Subcutaneous
- 8.6.4. Other
8.7. Market Attractiveness Analysis

9. Latin America Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Device
- 9.3.3. By Route of Administration
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 9.5.1. Syringes
- 9.5.2. Jet Injectors
- 9.5.3. Other Devices
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 9.6.1. Intradermal
- 9.6.2. Intramuscular
- 9.6.3. Subcutaneous
- 9.6.4. Other
9.7. Market Attractiveness Analysis

10. Middle East & Africa Vaccine Delivery Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Device
- 10.3.3. By Route of Administration
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Device, 2023 - 2030
- 10.5.1. Syringes
- 10.5.2. Jet Injectors
- 10.5.3. Other Devices
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
- 10.6.1. Intradermal
- 10.6.2. Intramuscular
- 10.6.3. Subcutaneous
- 10.6.4. Other
10.7. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Intramuscular
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Becton Dickinson & Company
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Bioject Medical Technologies, Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Inovio Pharmaceutical Inc.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. PharmaJet
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Vaxxas
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Gerresheimer AG
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. SCHOTT AG
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Corium International, Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. 3M
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations